WO2001012260A1 - Dispositif d'iontophorese destine a accroitre la penetration dans la peau de substances bioactives et/ou de supports de medicaments - Google Patents
Dispositif d'iontophorese destine a accroitre la penetration dans la peau de substances bioactives et/ou de supports de medicaments Download PDFInfo
- Publication number
- WO2001012260A1 WO2001012260A1 PCT/KR2000/000805 KR0000805W WO0112260A1 WO 2001012260 A1 WO2001012260 A1 WO 2001012260A1 KR 0000805 W KR0000805 W KR 0000805W WO 0112260 A1 WO0112260 A1 WO 0112260A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioactive material
- control unit
- transducer
- drug carrier
- ionphoresor
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 46
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 44
- 239000003937 drug carrier Substances 0.000 title claims abstract description 26
- 230000035515 penetration Effects 0.000 title abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 230000000699 topical effect Effects 0.000 claims abstract description 13
- 230000005611 electricity Effects 0.000 claims description 3
- 230000000977 initiatory effect Effects 0.000 claims description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 6
- 229930003268 Vitamin C Natural products 0.000 abstract description 6
- 239000002502 liposome Substances 0.000 abstract description 6
- 235000019154 vitamin C Nutrition 0.000 abstract description 6
- 239000011718 vitamin C Substances 0.000 abstract description 6
- 239000011159 matrix material Substances 0.000 abstract description 5
- 239000003963 antioxidant agent Substances 0.000 abstract description 4
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 235000006708 antioxidants Nutrition 0.000 abstract description 4
- 239000007970 homogeneous dispersion Substances 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000284 extract Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 1
- 241000933832 Broussonetia Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- -1 fluorouracils Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002353 niosome Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Definitions
- Iontophoretic device to enhance skin penetration of bioactive material(s) and/or drug carrier(s)
- This invention relates to an ionphoresor used for supply of electric
- ionphoresor which can facilitate penetration of a bioactive material or a
- bioactive material or a drug carrier encapsulating a bioactive material
- bioactive material or a drug carrier may easily penetrate into the skin.
- the ionphoresor of the present invention can maximize
- a bioactive material including an
- antioxidant like vitamin C exists in a charged form after ionization and a
- drug carrier including liposomes encapsulates bioactive material(s) of either
- hydrophilic or lipophilic properties and surface -charged as either negatively
- Figure 1 is a block diagram illustrating structural arrangements of
- Figure 2 is a conceptual sketch of the ionphoresor in actual use.
- a topical preparation 110 drug carrier
- transducer 1 transducer 2
- an ionphoresor of the present invention is so designed as to
- bioactive material or the drug carrier may penetrate easily into the skin by massaging with tender pressure to which a topical preparation, containing
- an ionphoresor of the present invention characteristically
- a power supply which provides electricity to each component ;
- control unit which monitors and regulates functions of each component ;
- a timer connected to the outlet of the current direction changer, which is operated by the signals from the control unit and controls time period for
- transducer 1 two transducer, designated as transducer 1 and transducer 2, respectively,
- a pressure sensor installed at one side of the tranducer 1, which is
- control unit and prevents overcurrents being applied to the human body by opening the line between the current direction changer and the transducer
- the ionphoresor of the present invention if a level of the signal from the pressure sensor is less than predetermined level. Furthermore, the ionphoresor of the present invention
- a resistance sensor which senses resistance of a
- ionphoresor of the present invention consists of a hydrophilic gel matrix in
- a bioactive material or a charged drug carrier(for example, liposome) for example, liposome
- encapsulating a bioactive material is homogeneously suspended.
- a bioactive material refers to any material that can exist in a charged form after ionization and includes such exemplary materials as
- whitening and antiageing agents such as arbutin, vitamin C and its
- antiinflammatory drugs including ketoprofen, corticosteroids including
- hydrocortisone and etc.
- a charged drug carrier refers to any drug carrier that exists in the
- vesicles and includes, e.g., liposome or niosome, and etc. Accordingly, no
- bioactive materials which are frequently encapsulated into the carriers of the present invention include lipid- soluble vitamins like gamma oryzanol
- anticancer agents like fluorouracils, antivirals like acyclovir, antihistamines
- seeweed extracts including chlorelline, aloe extracts, and etc.
- Figure 1 is a block diagram illustrating structural arrangements of the components of the ionphoresor of the present invention.
- Figure 2 is a conceptual sketch of the ionphoresor in actual use.
- the ionphoresor (200) of the present invention consists of such
- the power supply (210) provides electricity to each component of the ionphoresor(200).
- the control unit(220) monitors and controls functions of
- each component of the system and especially regulates the voltage level by
- timer(250 ) controls the timer(250 ) to allow flow of currents for a time
- level of the transducer 1(270) is less than predetermined level.
- the voltage adjuster(230 ) is operated by the signals from the
- control unit(220) and connected to the outlet of the power supply(210) in
- control unit(220) changes direction of the electric current supplied
- transducers designated as transducer 1(270) and transducer 2(271), respectively, connected to each of two outlets of the current direction
- transducer 2(271) installed on the outside of the
- control unit(220 ) which a topical preparation (100) has been applied. Then, control unit(220 )
- the human body by controlling the voltage adjuster(230). As illustrated in
- control unit(220) will change the direction of current flow, control
- the control unit(220) will control the skin determined by the pressure sensor(280).
- the ionphoresor of the present invention offers
- the ionphoresor of the present invention can maximize the effects
- hydrophilic matrix a bioactive material including an antioxidant like
- vitamin C exists in a charged form after ionization and a drug carrier including liposomes encapsulates bioactive material(s) of either hydrophilic
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne un dispositif d'iontophorèse capable de maximiser les effets d'une substance bioactive ou d'un médicament en facilitant sa pénétration dans la peau, en raison d'une force de répulsion exercée entre les mêmes charges électriques, dans le cas de massage de la peau après application d'une préparation à usage local, formulée par dispersion homogène d'une substance bioactive ou d'un support de médicament dans une matrice hydrophile. La substance bioactive renfermant un antioxydant tel que la vitamine C se présente sous une forme chargée après ionisation, et un support de médicament comprenant des liposomes encapsule la/ ou les substances bioactives de propriétés soit hydrophiles, soit lipophiles, avec charges superficielles négatives ou positives.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990034155A KR20010018270A (ko) | 1999-08-18 | 1999-08-18 | 전하공급 및 피부 맛사지 장치 |
KR1999/34155 | 1999-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001012260A1 true WO2001012260A1 (fr) | 2001-02-22 |
Family
ID=19607698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2000/000805 WO2001012260A1 (fr) | 1999-08-18 | 2000-07-26 | Dispositif d'iontophorese destine a accroitre la penetration dans la peau de substances bioactives et/ou de supports de medicaments |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20010018270A (fr) |
WO (1) | WO2001012260A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002094369A1 (fr) * | 2001-05-25 | 2002-11-28 | Nova Technical Research Gmbh | Dispositif d'introduction de substances |
WO2004073794A3 (fr) * | 2003-02-19 | 2004-11-25 | Yissum Res Dev Co | Dispositifs, procedes et eponges pour administration iontophoretique de medicament |
EP2319445A3 (fr) * | 2001-05-17 | 2011-09-28 | Transpharma Ltd. | Application de courant monopolaire et bipolaire pour administration transdermique de médicaments et extraction d'analytes |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2866240B1 (fr) * | 2004-02-16 | 2006-06-23 | Oreal | Kit de traitement comportant une structure composite a appliquer sur la peau et un excitateur electrique |
KR101479058B1 (ko) * | 2013-05-24 | 2015-01-07 | 주식회사 케이헬쓰웨어 | 이온토포레시스 투약 장치 및 투약 방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0309093A1 (fr) * | 1987-08-27 | 1989-03-29 | Hayashibara, Ken | Dispositif pour électrothérapie à basse fréquence |
US5090402A (en) * | 1987-08-12 | 1992-02-25 | L'oreal | Massaging appliance |
WO1997004731A2 (fr) * | 1995-07-25 | 1997-02-13 | Shmuel Pelz | Appareil pour massages |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03218763A (ja) * | 1988-12-12 | 1991-09-26 | Shinatsushin Kurinitsuku:Kk | マッサージ器 |
KR950008402Y1 (ko) * | 1993-02-10 | 1995-10-09 | 황현배 | 휴대용 피부관리기 |
KR960014098B1 (ko) * | 1993-12-17 | 1996-10-14 | 황현배 | 피부 관리기 및 그의 제어방법 |
KR960040387A (ko) * | 1995-05-12 | 1996-12-17 | 김응정 | 피부 미용 맛사지기 |
KR970020075A (ko) * | 1995-10-20 | 1997-05-28 | 이승진 | 이온 마사지기 |
KR200148926Y1 (ko) * | 1997-02-15 | 1999-06-15 | 김홍대 | 이온 맛사지기 |
-
1999
- 1999-08-18 KR KR1019990034155A patent/KR20010018270A/ko not_active Ceased
-
2000
- 2000-07-26 WO PCT/KR2000/000805 patent/WO2001012260A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5090402A (en) * | 1987-08-12 | 1992-02-25 | L'oreal | Massaging appliance |
EP0309093A1 (fr) * | 1987-08-27 | 1989-03-29 | Hayashibara, Ken | Dispositif pour électrothérapie à basse fréquence |
WO1997004731A2 (fr) * | 1995-07-25 | 1997-02-13 | Shmuel Pelz | Appareil pour massages |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2319445A3 (fr) * | 2001-05-17 | 2011-09-28 | Transpharma Ltd. | Application de courant monopolaire et bipolaire pour administration transdermique de médicaments et extraction d'analytes |
WO2002094369A1 (fr) * | 2001-05-25 | 2002-11-28 | Nova Technical Research Gmbh | Dispositif d'introduction de substances |
WO2004073794A3 (fr) * | 2003-02-19 | 2004-11-25 | Yissum Res Dev Co | Dispositifs, procedes et eponges pour administration iontophoretique de medicament |
US8290579B2 (en) | 2003-02-19 | 2012-10-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Device, methods and sponges for iontophoretic drug delivery |
Also Published As
Publication number | Publication date |
---|---|
KR20010018270A (ko) | 2001-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5006108A (en) | Apparatus for iontophoretic drug delivery | |
CA1274738A (fr) | Systeme electrique pour l'application transdermale d'un medicament | |
US5540669A (en) | Iontophoretic drug delivery system and method for using same | |
RU2320378C2 (ru) | Накожный аппликатор | |
EP0547482B2 (fr) | Système d'ionophorese comportant des moyens de réduction de l'irritation de la peau | |
KR101317990B1 (ko) | 마이크로전류-발생 국소 또는 미용 시스템, 및 제조 방법 및 그것의 용도 | |
CA2229872A1 (fr) | Dispositif d'iontophorese et procede approprie de regulation du courant | |
MY100987A (en) | Electrical dosimetry control system. | |
CA2200602A1 (fr) | Appareil d'administration par electrotransport | |
US5795321A (en) | Iontophoretic drug delivery system, including removable controller | |
AU4754696A (en) | Electrotransport device having reusable controller power saver | |
JPH027971A (ja) | 植え込み式除細動器用の二相パルス発生器 | |
EP0299615A3 (fr) | Procédé et appareil pour l'application d'iontophorèse des médicaments à pH commandé par échange d'ions | |
EP1009478A4 (fr) | Dispositif multicanal micro-courant a onde d'interferences, et technique de traitement par micro courant | |
CA2307283A1 (fr) | Appareil de defibrillation auriculaire au moyen de deux impulsions de choc | |
EP0836512A1 (fr) | Procede et appareil d'administration d'agents par electrotransport | |
US5983133A (en) | Iontophoresis system with voltage step-up circuit | |
AU6199996A (en) | Multiple therapy cardiac assist device having battery voltage safety monitor | |
MX9708823A (es) | Dispositivo de electrotransporte que tiene un controlador que se puede volver a usar. | |
WO2001012260A1 (fr) | Dispositif d'iontophorese destine a accroitre la penetration dans la peau de substances bioactives et/ou de supports de medicaments | |
US4850956A (en) | Device designed for subcutaneous transfer of medicinal substances | |
EP1458445B1 (fr) | Appareil permettant de fournir de l'energie de defibrillation et de stimulation cardiaque a partir d'une seule source d'alimentation | |
EP1163025B1 (fr) | Systeme de regulation de la transpiration | |
EP0783345A1 (fr) | Systeme d'administration d'un medicament par ionophorese, comprenant un timbre a usage unique et un dispositif de commande amovible, reutilisable | |
WO1999006106A1 (fr) | Appareil pour stimulation electrique du corps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA CN DE GB JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |